Immunovant Inc
IMVT
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.63B
Close$
$4.94
88.2% downside
Current Fair Value
88.2% downsideOvervalued by 88.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.63 Billion |
|---|---|
| Enterprise Value | $7.83 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.77 |
| Beta | 0.81 |
| Outstanding Shares | 205,545,373 |
Return
| Return on Equity | -73.19% |
|---|---|
| Return on Assets | -63.13% |
| Return on Invested Capital | -60.45% |
Valuation & Multiples
| P/E Ratio | -14.83 |
|---|---|
| PEG | -54.85 |
| Price to Sales | - |
| Price to Book Ratio | 13.94 |
| Enterprise Value to Revenue | 1104.15 |
| Enterprise Value to EBIT | -17.62 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$-0.60
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.69
Average shareholder expectationRevenue Estimate
$7.09 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2700▲ 16.54% |
|---|---|
| Total Calls | 20,000▼ 99.20% |
| Total Puts | 5,400▼ 97.95% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 8.88%▼ 51.75% |
|---|---|
| Total Invested | $696.33M▼ 74.65% |
| Investors Holding | 75▼ 151.00% |
ESG Score
No data